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Background: Alus are primate-specific retrotransposons which account for 10.6% of the human genome. A large
number of protein-coding mRNAs are encoded with sense or antisense Alus in the un-translated regions.
Results: We postulated that mRNAs carrying Alus in the two opposite directions can generate double stranded
RNAs, capable of regulating the levels of other Alu-carrying mRNAs post-transcriptionally. A gene expression
profiling assay showed that the levels of antisense and sense Alus-carrying mRNAs were suppressed in a reversible
manner by over-expression of exogenous sense and antisense Alus derived from mRNAs (Family-wise error rate
P= 0.0483 and P < 0.0001 respectively). Screening through human mRNAs on the NCBI-RefSeq database, it was
found that sense and antisense Alu-carrying transcripts were enriched in distinct cellular functions. Antisense
Alu-carrying genes were particularly enriched in neurological and developmental processes, while sense
Alu-carrying genes were enriched in immunological functions.
Conclusions: Taken together, we proposed a novel Alu-mediated regulation network capable of stabilizing
Alu-carrying mRNA levels in different cell types and restricting the activated expression levels of protein-coding,
Alu-carrying mRNAs.
Keywords: Antisense Alu, Gene expression restriction, Double-stranded Alu, Alu-carrying protein-coding RNABackground
An intriguing characteristic of the human genome is its
containing of vast numbers of Alus, a class of short-
interspersed repetitive sequences with a length of
280~300 nucleotide bases [1-3]. More than one million
copies of Alus altogether contribute 10.6% of the human
genome [1,2]. Alus were retrotransposons evolved from
a duplication of the 7SL RNA gene more than 65 million
years ago [1-4]. The retrotransposition process of Alus
relies on the machinery carried by the long interspersed
nucleotide element 1 (L1), another retrotransposon
which contributes 17% of the human genome [4,5]. Alus
have diverse sequence variations [6,7]. A total of 213 Alu
subfamilies have been reported based on a thorough
computation of sequence homology in the human gen-
ome [2].* Correspondence: chautingy@gmail.com
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reproduction in any medium, provided the orAlus were found in both genic and intergenic re-
gions of the human genome [3], with a higher fre-
quency in the former [8]. Intergenic Alus can be
transcribed by polymerase III, yet the transposition
activities have remained dormant [9]. Polymerase III-
derived Alu transcripts are constantly shattered by
Dicer1 in normal human physiology, failure of which
may result in Alu toxicity which in turn triggers geo-
graphic atrophy [10], an advanced form of age-related
macular degeneration.
Genic Alus have been found in upstream and intronic
regions [11], as well as exonic regions such as 5′ un-
translated regions (UTRs) [12] and 3′UTR of messenger
RNAs [3]. Alus in mRNAs are classified as exonic or
exonized Alus, depending on whether they are embed-
ded within a longer exon or are spliced into mRNAs asal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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express only occasionally and have low copies of tran-
scripts within cells [12,13]. Alus have been shown to en-
compass a 6-base sequence tag complimentary to one
common seed of 30 human miRNAs [14]. Recently, long
non-coding RNAs have been shown to be capable of
binding to Alu-carrying mRNAs, thereby triggering the
STAU1-mediated mRNA decay [15]. An analysis of
human chromosomes 21 and 22 showed that genic Alus
are particularly enriched in genes of metabolism, trans-
port and signaling processes [16]. Despite these analyses,
the cellular roles of genic Alus remain largely elusive
[3,8,11]. Alus were once thought of as parasite-like,
selfishly-replicated junk DNAs without prominent con-
structive roles to human cells [13,17].
Human mRNAs may carry Alus in either sense or
antisense directions. In light of the thermodynamics
properties of nucleotide base pairing, we were in-
trigued to ask whether these mRNAs form double
stranded duplex longer than 290 bases, and if that
happens, what their corresponding cellular roles could
be? Despite the binding of two protein-coding
Alu-carrying mRNAs had never been discussed previ-
ously to our knowledge, we conjectured that the
resulting double stranded RNAs could trigger the
post-transcriptional regulation of a large collection of
protein-coding mRNAs carrying sense or antisense
Alu elements, by offering potent sources of either
Dicer1-created short interfering RNA (siRNA) [18-20],
or STAU1-mediated mRNA decay [15]. Both mecha-
nisms were originally proposed to address the binding
of a non-coding and a protein-coding RNA.
An Alu-carrying mRNA may form a binding with
multiple antisense Alu-carrying mRNA, and vice
versa. Consequently, mRNAs with sense and antisense
Alu elements produce a many-to-many network,
where those with the sense elements are prevailingly
regulated by those with the antisense elements,
resulting in coordinated reaction. Such coordination
has been postulated recently on the topic of micro
RNAs (miRNA) against genes, pseudogenes and long
non-coding RNAs which share the same miRNA tar-
gets [21,22]. Intriguingly, Vidal and colleagues showed
that mouse and rat mRNAs carrying sense B1 repeats
are expressed coordinately, reaching a maximum level
in the G2 phase of the cell cycle [23]. Data showed
that the B1 repeats are necessary rather than suffi-
cient criteria for the coordination. It is worth notingTable 1 Two genes with Alu sense or antisense elements in th
Gene symbol Alu direction RefSeq accession ALU region
PER2 antisense NM_022817.2 5318-5631
PCM1 sense NM_006197.3 7691-8008that B1 repeats (~140 bases) were also originated
from 7SL RNA gene [6].
Results
Strong sense-antisense bindings of Alu-carrying mRNAs
predicted by RNA co-folding computation
The first conjecture was the binding of messenger RNAs
carrying sense and antisense Alus. Inspired by Vidal and
colleagues’ work on cell cycles [23], our exploration
started from two genes carrying respectively the sense and
antisense Alu elements, PCM1 (which is known for its
role on cell cycles) and PER2 (a major gene in circadian
cycles) (Table 1). The co-folding structure of the two full-
length mRNAs was computed, showing a long forma-
tion of RNA duplex of 318 bases which clearly stood out
from other local structures (Figure 1A). This duplex was
formed by the base pairing of sense and antisense Alus
(Figure 1B). The estimated free energy of the duplex
is −461.3 kcal/mol. Deducting the free energy of the two
elements in isolation (−102.2 and −123.4 kcal/mol
respectively), the net change of energy (denoted as ΔG)
is −235.7 kcal/mol [24] which indicated a strong en-
couragement of binding and provided positive evidence
supporting the first conjecture.
Protein-coding mRNAs with Alu elements in opposite
directions also carry distinct biological functions
The second conjecture was that the duplex of Alu-
carrying mRNAs may trigger subsequent degradations
of other Alu-carrying RNAs. If such mechanism ex-
ists, it follows that sense Alu-carrying mRNAs (re-
ferred to as Sens-alus) and antisense Alu-carrying
mRNAs (Ant-alus) cannot concurrently stay in high
concentrations in human cells. Instead, there are
three possibilities: (i) Ant-alu high and Sens-alu low;
(ii) Ant-alu low and Sens-alu high; (iii) both Sens-alu
and Ant-alu are low. In other words, states (i) and
(ii) represent the dominant expression patterns of
only one Alu-carrying RNA species. As such, a RNA
species might be enriched in certain pathways, while
depleted in other pathways, resulting in different
functional annotations of the two species. The corre-
sponding null hypothesis is that states (i) and (ii)
does not exist and their constituent genes are ran-
domly scattered in a wide spectrum of biological cat-
egories and pathways. This hypothesis can be assessed
by checking the over and under representation of
genes in pathways and biological processes.e 3′UTR
Length 3′UTR Exon containing the ALU GC%
314 4005-6342 3856-6342 52.9
318 6497-8788 6472-8783 52.8
Figure 1 Secondary structures of PER2 and PCM1 mRNAs predicted by a co-folding algorithm. (A) The co-folding of full length mRNAs of
PER2 (Green) and PCM1 (Red). A long line of duplex structure was observed. (B) A focused view of the duplex caused by the antisense base
pairing of Alus on PER2 (Green) and PCM1 (Red).
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NCBI-RefSeq human mRNAs [25] using sequence hom-
ology search. A majority of these Alu elements reside in
the 3′UTR (99%) and only 1% of them reside in the 5′
UTR region. None of them were found to reside com-
pletely in the coding region. 689 Ant-alus and 771 Sens-
alus were identified respectively, resulting in a total sum
of 1460 genes which corresponds to 7.3% of human
protein-coding genes (Additional file 1: Table S1,
Additional file 1: Table S2). Computational analysis on a
random selection of pairs of Ant-alus and Sens-alus
showed that all of them can form computational predicted
bindings with ΔG lower than −200 kcal/mol. In addition,
190 genes were found to have Alu elements in both sense
and antisense directions (Additional file 1: Table S3).
Functional annotations of Ant-alus and Sens-alus
showed that the two RNA species were differently dis-
tributed in multiple pathways and biological functions.
Ant-alus were over-represented in multiple signaling
pathways of neurotransmitters such as serotonine,
gamma aminobutyric acid (GABA), glutamate, acetyl-
choline and cannabinoid. They were also over-
represented in synaptic vesicle trafficking, opioid and
(dopamine producing) pyridoxal phosphate pathways
(P<0.05; Table 2). Ant-alus were under-represented only
in the Huntington disease pathway (Table 2). Addition-
ally, Ant-alus were over-represented in the biological
processes such as dorsal-ventral axis, exocytosis, neuro-
transmitter secretion, organelle organization and vesiclemediated transport (Table 3). Ant-alus were under-
represented in the biological processes of anion trans-
port, nerve-nerve synaptic transmission and response to
stimulus and toxins (Table 3).
On the other hand, Sens-alus were over-represented
in immunological pathways such as Toll-like recep-
tors, Interleukin and endothelin signaling (P<0.05,
Table 2). Sens-alus were not under-represented in any
pathways. Sens-alus were also over-represented in
biological processes related to cytokine-mediated sig-
naling pathway, responses to interferon gamma and
meiosis. Sens-alus were under-represented in synaptic
transmission and ectoderm development (Table 3).
Interestingly, Ant-alus were over-represented (P =
0.0007) while Sens-alus were under-represented (P =
0.0333) in the biological process of synaptic vesicle
exocytosis (Table 3).
A scrutiny of the constituent genes revealed that the
Sens-alus species has greater numbers of immune-
related genes, particularly the Toll-like receptors, Cyto-
kines and Cluster of differentiations, than Ant-alus
(Table 4). On the contrary, the Ant-alu species has more
embryonic stem cell-related genes than Sens-alus
(Table 5). The distinct functional annotations of Sens-
alus and Ant-alus in our analysis suggested that the in-
sertion and maintenance of Alus in mRNAs in the two
directions were not entirely random. Instead, these
protein-coding genes might mediate regulatory processes
via Alu elements for special functions.
Table 2 List of all pathways where Sens-alus and Ant-alus
are enriched or depleted
Pathway Ant-alu P Sens-alu P
Ant-alu enriched
p53 pathway 0.0005† 0.2470
Opioid prodynorphin pathway 0.0015† 0.6090
Muscarinic acetylcholine receptor









5HT1 type receptor mediated
signaling pathway
0.0077† 0.2930
Opioid proopiomelanocortin pathway 0.0088† 0.4040






Muscarinic acetylcholine receptor 1












p53 pathway feedback loops 2 0.0407 0.1580
Angiotensin II-stimulated signaling
through G proteins and beta-arrestin
0.0438 0.5690
Ant-alu depleted
Huntington disease 0.0230 0.3950
Sens-alu enriched





Gamma-aminobutyric acid synthesis 0.8130 0.0229
SCW_signaling_pathway 0.4430 0.0289
BMP_signaling_pathway-drosophila 0.4430 0.0289
Interleukin signaling pathway 0.5740 0.0365
Endothelin signaling pathway 0.3140 0.0420
DPP-SCW_signaling_pathway 0.5150 0.0487
†The accompanying False Discover Rate < 25%.
The P values were nominal values without being corrected for multiple
comparisons.
Liang and Yeh BMC Genomics 2013, 14:325 Page 4 of 13
http://www.biomedcentral.com/1471-2164/14/325One possibility for such a difference of Ant-alus and
Sens-alus in pathway distributions is that certain genes
underwent duplication events, after Alu retrotransposed
into these genes, producing a number of paralogs of
Alu-carrying genes associated to similar functions. As
the primate-specific Alu incorporation events were fairly
recent in evolution (~65 million years), these paralogs
should still remain in the same protein subfamilies. To
check this possibility, we checked the protein subfamilies
among Ant-alus and Sens-alus. It was found that 96.2% of
Ant-alus and 96.9% of Sens-alus have unique subfamilies
(Additional file 1: Table S1, Additional file 1: Table S2),
leaving 3.8% of Ant-alus and 3.1% of Sens-alus associated
to the same protein subfamilies with others. This suggests
that the gene duplication events accounted for a smaller
fraction of pathway distributions than direct Alu retro-
transposition. That said, gene duplication and Alu incorp-
oration were both parts of evolution which jointly shaped
the human genome and its biological functions. The
functional annotation was thus based on the final set of
Alu-carrying genes till this point in evolution.
Significant suppression of Alu-tagged mRNAs by Alu
perturbations
An extrachromosomal replication system was estab-
lished to examine the perturbation of Alu-carrying genes
in response to elevated Alu RNAs in the opposite
direction. The null hypothesis here is that the
Alu-carrying RNA duplex cannot trigger subsequent
post-transcriptional regulation, manifesting a random
fluctuation of expression levels. Transfected sense and
antisense Alus were first checked to have expressed suc-
cessfully, by the detection of chimeric RNA sequences
expressed from the artificially constructed template
sequence encompassing both vector and Alus.
Genome-wide RNA expressions were measured in 6
different treatment conditions defined in the legend of
Figure 2. Average levels of Ant-alu and Sens-alu were
below the genome-wide average levels in all 6 conditions
(Figure 2A). A Gene Set Enrichment Analysis (GSEA)
was employed due to its capability of assessing the group
behavior of a set of genes [26,27], a favorable feature for
our examination of protein-coding mRNAs carrying Alus
in opposite directions. As a group, Sens-alus were signifi-
cantly suppressed in terms of family-wise error rate
(FWER) (P < 0.0001), while Ant-alus were not significantly
suppressed in response to antisense Alus transfection
(P = 0.1008), using cells transfected by empty vectors as
controls (Figure 2B, upper panels). In contrast, Ant-alus
were significantly suppressed (P = 0.0483), while Sens-alus
were not significantly suppressed in response to sense
Alus transfection (P = 0.1017) (Figure 2B, lower panels).
After the removal of selection antibiotics (Hygromycin),
exogenous sense and antisense Alu RNAs gradually
Table 3 List of all biological processes where Ant-alus
and Sens-alus are either enriched or depleted
Biological process Ant-alu P Sens-alus P
Ant-alus enriched
exocytosis 0.0003† 0.0807
synaptic vesicle exocytosis 0.0007† 0.0333
neurotransmitter secretion 0.0011† 0.1060
polysaccharide metabolic process 0.0022 0.4470
organelle organization 0.0033 0.3170
establishment or maintenance of
chromatin architecture
0.0056 0.3100
mammary gland development 0.0090 0.0841
glycogen metabolic process 0.0153 0.5300
protein targeting 0.0183 0.4670
dorsal/ventral axis specification 0.0263 0.2970
vitamin catabolic process 0.0339 0.9620
catabolic process 0.0339 0.9620
cellular amino acid catabolic process 0.0385 0.5430
Ant-alus depleted
anion transport 0.0069 0.4800
visual perception 0.0132 0.5310
developmental process 0.0133 0.1630
nerve-nerve synaptic transmission 0.0148 0.3080
neuromuscular synaptic transmission 0.0153 0.5010
sensory perception 0.0218 0.4540
response to toxin 0.0327 0.5300
response to stimulus 0.0351 0.2500
cell motion 0.0439 0.2520
cell-cell adhesion 0.0469 0.3020
Sens-alus enriched
cyclic nucleotide metabolic process 0.5180 0.0040
termination of RNA polymerase II transcription 0.5570 0.0289
response to interferon-gamma 0.3500 0.0335
meiosis 0.2210 0.0346
cytokine-mediated signaling pathway 0.3820 0.0396
RNA localization 0.2320 0.0397
Sens-alus depleted
ectoderm development 0.1360 0.0234
mRNA 3′-end processing 0.2320 0.0255
mRNA polyadenylation 0.2200 0.0275
synaptic transmission 0.1390 0.0285
macrophage activation 0.4460 0.0387
cellular glucose homeostasis 0.0732 0.0390
embryonic development 0.4190 0.0450
defense response to bacterium 0.0749 0.0457
†The accompanying False Discover Rate < 25%.
The P values were nominal values without being corrected for multiple
comparisons.
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ingly. At week 1, only Sens-alu were significantly different
from week 0 (Ant-alu P = 0.2503, Sens-alu P = 0.0479).
In addition to the GSEA evaluation of group behav-
iors, we also performed analysis on individual probe
sets. Ant-alus were selected if they manifested signifi-
cant down regulation in response to sense Alu transfec-
tions (P< 0.0005, FDR < 0.0321). The fold change of
RNA level was between 31.1% and 92.5%. Their expres-
sion levels across all 6 conditions were shown as a
heatmap in Figure 2C. It showed that in addition to the
suppression by sense Alus, the same set of genes can
also be suppressed by antisense Alus. Sens-alus were
selected if they manifested significant down regulation
in response to antisense Alu transfetions (P< 0.0005,
FDR < 0.0518). The fold change of RNA level was
between 29.6% and 95.4%. Again, the heatmap showed
that the same set of genes can also be suppressed by
sense Alu (Figure 2D).
We also conducted a smaller-scale experiment for
measuring the protein abundance of several randomly
selected Sens-alus and Ant-alus, in response to the
transfection of Alus in opposite directions, using western
blotting. This time, the protein abundances were mea-
sured repeatedly once a week up to the 8th week after
the selection antibiotics were removed (Figure 2E and 2F).
The exogenous sense and antisense Alu RNAs gradually
reduced to <25% at week 8 (compared with the maximum
level at week 0), and protein suppression effects were
observed during the period while the exogeneous Alu was
still present.
Discussion
A regulatory network mediated by Alu RNA duplex
Alus contribute a significant portion of the human gen-
ome. However, their cellular roles remain largely elusive.
A better understanding of Alus’ roles can substantially
enhance our overall knowledge on the human genome.
We demonstrated that two species of mRNAs, harboring
sense or antisense Alus respectively, could form a long
RNA duplex longer than 290 bases. Also, the co-
existence of sense and antisense RNAs in a cell can
trigger group post-transcriptional regulation of two sets
of Alu-carrying mRNAs. It is important to note that the
intergenic, polymerase (pol) III-directed Alu RNA tran-
scripts may also hybridize with Ant-alus due to similar
thermodynamic base pairing. Further, long non-coding
RNAs have been reported to hybridize with mRNAs
with Alu elements [15]. Taken together, a static network
of Alu-mediated interactions was conceptualized, com-
prising four Alu-carrying RNA species: Ant-alus,
Sens-alus, Pol-III derived Alus, and long non-coding
Alu-carrying RNAs (Figure 3A). At the center stage are
protein-coding Ant-alus and Sens-alus. An altered
Table 4 Comparison of immune-related genes in Ant-alus and Sens-alus
Ant-alus Sens-alus
Gene symbol RefSeq accession Gene symbol RefSeq accession
V(D)J recombination DCLRE1C NM_001033855.1
Toll like receptors TLR6 NM_006068.3
TLR7 NM_016562.3
TLR10 NM_030956.2
Interferon related IRF1 NM_002198.2
IFIT3 NM_001031683.2; NM_001549.4
Cytokines IL11 NM_000641.2 IL1R1 NM_000877.2
IL28RA NM_170743.2; IL2RA NM_000417.2
NM_173064.1;
NM_173065.1















Chemokines CCL22 NM_002990.3 CCL5 NM_002985.2
CXCL16 NM_022059.2 CCR6 NM_031409.3;
NM_004367.5
Cluster of differentiation CD24 NM_013230.2 CD28 NM_006139.2
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Table 4 Comparison of immune-related genes in Ant-alus and Sens-alus (Continued)
HLA and related receptors FCAR NM_133279.2 HLA-DOA NM_002119.3

















Others NLRC3 NM_178844.2 PCM1 NM_006197.3
DDX51 NM_175066.3
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tire system, thereby changing cellular states.
What could be the major driving forces for the
dynamics of the network? Environmental stimuli such as
stress may be one answer. It was reported that Pol III
derived Alu transcripts, usually dormant in normal cell
conditions, were elevated by stress such as viral infection
[9,17,28]. Pol III Alu may be perturbed together with all
the other species upon stress response, although the
physiological level of perturbation of the four RNA
species remained elusive.
Data from the in-vitro system showed that the Sens-
alus and Ant-alus were suppressed significantly by
transfected Alu counterparts. The transfected sense Alu
could represent over-expressed Sens-alus, or the Pol-III
derived Alus, as both of them have similar Alu elements
in the sense direction to suppress its counterparts. Like-
wise, the transfected antisense Alu could represent over-
expressed Ant-alus, or long non-coding transcripts with
antisense Alu elements.
The strong binding of genes with opposite Alu direc-
tions was predicted by the RNA folding algorithm. The
empirical evidence of the binding was still lacking. We
have been planning an experiment based on the idea of
using multiple Alu-carrying genes as baits. A binding
column will be used to capture the baits. Those RNA
bind to the baits can also be captured and then analyzed.
This however remained to be our future work.The network of the Alu-carrying RNAs may underlie
the stability and transitions of human cellular states such
as neurological or immunological response, as was sug-
gested by the functional annotations of protein-coding
Alu-carrying mRNAs. First, the mutual suppression
effect may offer barriers among cell lineages. Random
fluctuations of Alu-carrying genes may be restricted by
the network. Second, upon the invasion of pathogens,
the immune system must respond quickly to turn the
immature immune cells into mature states by coordi-
nated activations of genes, many of which are Sens-Alus
(Table 4).
Activation restriction for gene expression cascades
Previous work by Vidal and colleagues showed that the
B1-repeat elements are necessary rather than sufficient
criteria for the co-expression of genes, implying that
some, but not all, B1-containing genes are activated con-
currently [23]. Developmental processes, neurological
and immunological functions have been known to
comprise many signal transduction events. We contin-
ued to reason that, when a signal transmits to a set of
Alu-containing genes, they may be activated by way of
elevation of their expression levels. The Alu-mediated
suppressing effect offers a built-in inhibitory mechanism
toward other Alu-tagged RNA species despite the pres-
ence of their individual activation signals from the noisy
environment. The net effect is a restricted activation of
Table 5 List of embryonic stem cell related genes in Ant-alus and Sens-alus
Gene symbol RefSeq accession Gene name
Ant-alus
ANGEL2 NM_144567.3 Protein angel homolog 2
CBX5 NM_012117.2; NM_001127321.1; NM_001127322.1 Chromobox protein homolog 5
CD24 NM_013230.2 Signal transducer CD24
CDC6 NM_001254.3 Cell division control protein 6 homolog
CDH1 NM_004360.3 cadherin 1, type 1, E-cadherin (epithelial)
CECR1 NM_017424.2; NM_177405.1 Cat eye syndrome critical region protein 1
DHFR NM_000791.3 dihydrofolate reductase
DPPA4 NM_018189.3 Developmental pluripotency-associated protein 4
FAM108B1 NM_001025780.1 Abhydrolase domain-containing protein FAM108B1
GNPTAB NM_024312.3 N-acetylglucosamine-1-phosphotransferase subunit beta
MICB NM_005931.3 MHC class I polypeptide-related sequence B
NANOG NM_024865.2 Homeobox protein NANOG
NUDT15 NM_018283.1 Probable 7,8-dihydro-8-oxoguanine triphosphatase NUDT15
PDK1 NM_002610.3 3-phosphoinositide-dependent protein kinase 1
PFAS NM_012393. Phosphoribosylformylglycinamidine synthase
PHF17 NM_024900.3 Protein Jade-1
RPS24 NM_001142285.1 ribosomal protein S24
RRM2 NM_001034.3; NM_001165931.1 Ribonucleoside-diphosphate reductase subunit M2
RRP15 NM_016052.3; RRP15-like protein
SFRS1 NM_006924.4; NM_001078166.1 Splicing factor, arginine/serine-rich 1
TDGF1 NM_003212.2 Teratocarcinoma-derived growth factor 1
TERF1 NM_003218.3; NM_017489.2 Telomeric repeat-binding factor 1
Sens-alus
ATP1A2 NM_000702.3 Sodium/potassium-transporting ATPase subunit alpha-2
CDT1 NM_030928.3 DNA replication factor Cdt1
DSG2 NM_001943.3 Desmoglein-2
LIN28 NM_024674.4 Lin-28 homolog A
MCM4 NM_005914.2; NM_182746.1 DNA replication licensing factor MCM4
NCAPH NM_015341.3 Condensin complex subunit 2
NFYB NM_006166.3 Nuclear transcription factor Y subunit beta
PAICS NM_006452.3; NM_001079524.1; NM_001079525.1 Phosphoribosylaminoimidazole carboxylase
PIPOX NM_016518.2 Peroxisomal sarcosine oxidase
PPM1B NM_177968.2 Protein phosphatase 1B
PRDM14 NM_024504.2 PR domain zinc finger protein 14
PRKX NM_005044.3 Serine/threonine-protein kinase PRKX
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unwanted signals are filtered away. This situation will
persist till the formal signaling effect has subsided. Then,
another signaling can come through, resulting in a se-
quence of gene expressions. A full scale of disordered
responses is thus prevented, and the activation of
Alu-containing genes can proceed in a coordinated fash-
ion, one state after another (Figure 3B and 3C).One key question about the mutual regulation of
Sens-alus and Ant-alus is the responsible molecular
mechanisms. Is it through the Dicer1-created siRNA
mechanism, the STAU1-mediated RNA degradation, or
both? Our data suggested that Dicer1 may play a bigger
role. An interesting observation from our experiments is
that Alu-carrying genes can be suppressed by transfected
Alus in the same direction, although not to the level of
Figure 2 (See legend on next page.)
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(See figure on previous page.)
Figure 2 Expression levels of Sens-alus and Ant-alus upon Alu perturbations. (A) An overview plot of Sens-alus, Ant-alus and genome-wide
RNA levels across 6 different treatment conditions. HEK293 cells were transfected with (1) empty pDR2 vectors (pDR2; Hygromycin added); (2)
antisense Alus with Hygromycin selection (pDR2-anti-Alu; Hygromycin added; week 0); (3) the same as (2) with Hygromycin removed
subsequently (pDR2-anti-Alu; Hygromycin added→removed; week 1); (4) sense Alus with Hygromycin selection (pDR2-sense-Alu; Hygromycin
added; week 0); (5) the same as (4) with Hygromycin removed subsequently (pDR2-sense-Alu; Hygromycin added→removed, week 1); and (6) the
original HEK 293 cells (no treatment). Vertical bars, means of expression levels per various gene sets from triplicate experiments. Error bars,
standard deviations. (B) GSEA plots for the suppression effects of Ant-alus (upper left) and Sens-alus (upper right) in response to antisense Alu
transfections, as well as sense Alu transfections (lower left and right respectively). NES, Normalized enrichment score. (C) The heatmap of a
collection of Ant-alu genes which showed significant suppression individually upon sense Alu transfection, using cells transfected by empty
vectors as controls (P< 0.0005, FDR < 0.0321). Green color indicated suppression. (D) The heatmap of a collection of Sens-alu genes which
showed significant suppression upon antiense Alus transfection (P< 0.0005, FDR < 0.0518). (E) A heatmap representation of protein expressions of
randomly selected Ant-alu genes, quantified at different time points by western blotting, up to the 8th week after the removal of Hygromycin.
Protein levels of cells transfected by empty vectors (pDR2) were presented as baselines. Numbers in the time axis indicated weeks after
Hygromycin removal. The time-course profile of extrachromosomal expression of sense Alu RNA was also presented. (F) Protein levels of
randomly selected Sens-alu genes quantified at different time points. The time-course profile of exogeneous antisense Alu RNA was presented.
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tent source of siRNA offered by the duplex of transfected
sense Alu and Ant-alu, upon the cleavage of Dicer1, which
may suppress both Sens-alus and Ant-alus depending on
the guide strand directions [18]. Sens-alus were thus
suppressed by the RNA-induced silencing complex using
siRNAs in the antisense strand as the guide strand. Inter-
estingly, Dicer1 is also down regulated in chemically
stressed cells [3]. Recent data also showed the intimate
trade-off between Dicer1 and Alu abundance [10].
Conclusions
In summary, we proposed a complex regulation network
mediated by the Alu “tags” in four species of RNAs and
offered initial evidence. The Alu-mediated suppression
effect may restrict the activation of genes with other
“tags”, thereby stabilizing state transitions observed
along cellular lineages or in response to outside stimuli.
Additionally, different ratios of Sens-alus and Ant-alus
may be observed in different types of human cells, with
two extreme examples of Ant-alus or Sens-alus as the
predominant constituents of expressed genes. The
former state may be related to neurological functions,




An in-vitro extrachromosomal replication system was
established to examine the postulated regulation effects
on genes carrying the Alu elements. Sense and antisense
Alus were cloned from cDNAs, which were reversely
transcribed from mRNAs of PCM1 (nt 7636 to nt 8082;
[RefSeq:NM_006197.3]) and PER2 (nt 5221 to nt 5781;
[RefSeq:NM_022817.2]), respectively. The clones were
then inserted into pDR2 vectors (Clontech, Mountain
View, CA) downstream of the Rous sarcoma virus long
terminal repeat (LTR) promoter. This plasmid vectorcontains Epstein-Barr virus OriP, a gene for hygromycin
B selection, and an ampicillin resistance gene. These two
plasmids, and a pDR2 vector carrying no additional
DNA (the empty vector), were transfected to human em-
bryonic kidney cells constitutively expressing Epstein-
Barr virus nuclear antigen-1 (EBNA-1) protein from
Epstein-Barr virus (Hek293EBNA cells; Invitrogen,
Carlsbad, CA). The three cell lines were maintained in
Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum and 250 ug of G418 per ml.
Hygromycin (0.6 mg/ml) was added to the cell culture
medium for the selection of stable transformants. After
the transfection, the RNA extracts were submitted for
RT-PCR, cloning and sequencing to check whether the
expressed RNA encompasses both the vector part and
the inserted sequence, an evidence that the transfected
sequence has successfully expressed in our system. Real-
time PCR was also performed to monitor the expression
levels of the exogenous transcripts weekly after removal
of hygromycin from the culture medium. Upon removal
of hygromycin, the extrachromosomal replicating plas-
mids were gradually lost, allowing for reversion to the
un-transfected status.
The mRNA of Sens-alus and Ant-alus, in response to
the transfection, were measured by gene expression
microarray. Affymetrix Human PrimeView™ arrays were
used (Affymetrix, Santa Clara, CA). An in vitro tran-
scription (IVT) with biotinylated ribonucleotide analog
were then performed to generate biotin-labeled ampli-
fied RNA (aRNA), using GeneChip 3′IVT Express kit
(Affymetrix, Santa Clara, CA). The aRNAs were then
purified by magnetic beads and fragmented for the sub-
sequent hybridization according to the manufacturer’s
protocol. Fluorescent signal was scanned by GeneChip
Scanner 3000 7G (Affymetrix, Santa Clara, CA) to pro-
duce digital images and then converted and summarized
to intensity readings per probe sets (total n= 49395).
The protein expression levels of several Alu-containing
Figure 3 (See legend on next page.)
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Figure 3 Gene activations and suppressions mediated by Alu-carrying RNAs. (A) A conceptual interaction network, where any two RNA
species that may form a long (280~300 bp) Alu duplex were depicted by mutual inhibition signs. Central to the regulation network are Ant-alus
and Sens-alus, which together represent 7.3% of total protein-coding genes. Their RNA levels may affect downstream protein levels. Pol III derived
Alus may also form a binding with Ant-alus, enabling a mutual regulation. A few non-coding RNAs (ncRNAs) have also been reported elsewhere
to bind with Sens-alus and then trigger STAU1-mediated mRNA decay. (B) The activation restriction model. A set of alu-carrying genes was
activated and increased expression level in response to outside stimulation. The elevation of these genes increased the Alu element in the
cytosol, which can suppress the activation of other Alu-carrying genes which are associated to other pathways. The suppression will continue
until the original signal has subsided. Then a new activation can proceed. (C) Waves of genes are activated coordinately, with different set of
genes activated in different time, due to Alu-mediated suppression.
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raw and normalized data can be found on the NCBI
GEO repository by the accession number GSE39822.
Bioinformatics
RNA secondary structures of full length mRNA of PER2
and PCM1 were predicted using the standalone RNA-
cofold software offered by the Vienna RNA group
[29,30].
The Alu elements in PCM1 (nt 7691 to nt 8008;
[RefSeq:NM_006197.3]) and JAK3 (nt 4299 to nt 4614;
[RefSeq:NM_000215.3]) were used as query sequences to
search against the entire NCBI-RefSeq database [25] for
antisense hits using the command-line Yass alignment
software [31]. Standard parameters were used, and hits
must have e-values smaller than 10-20 and length longer
than 290 bases. This parameter setting allowed non-
perfect matches. The coding regions annotated by NCBI-
Refseq were also used to discern whether the antisense
hits were located in 5′UTR, 3′UTR or the coding regions.
Protein-coding genes were sieved from the Alu-
carrying transcripts using the PANTHER (Protein
ANalysis THrough Evolutionary Relationships) Classifi-
cation System version 7.2 on the official bioinformatic
site [32]. PANTHER is a sequence based, phylogenic-
tree supported system with protein functions annotated
by human experts, ensuring a high quality of annotation.
Sens-alus were defined by genes with Alus only in the
sense direction while Ant-alus were defined by genes
with Alus only in the antisense direction. The subfam-
ilies of Sens-alus and Ant-alus were assigned by
PANTHER. Functional annotations of over- or under-
representation of Ant-alus and Sens-alus amongst
various pathways and biological functions were also
performed by PANTHER. Gene symbols of 689 and 771
genes were submitted to the website, and the functional
annotations of pathways and biological processes of the
two lists of genes were calculated concurrently by the
system. A total of 165 pathways and 212 biological pro-
cesses were checked individually to see the level of over-
and under-representation of the two lists of genes. The
P values were derived using the binormial distribution
tests. False discovery rates (FDR) were also calculated to
accompany the P values, addressing issues of multiplecomparisons. The downloadable results were in the
format similar to Tables 2 and 3.
The expression levels across all 18 microarrays (for 6
conditions, each with three biological replicates) were
normalized using the RMAExpress (version 1.0.5), imple-
menting the Robust multiarray analysis (RMA) algorithm
[33-35]. Gene expression levels per probe set were
compared across groups using unpaired two sample t-test
assuming unequal variance. False discovery rates (FDR)
were used to assess significance in the scenario of multiple
comparisons. All P-values were two-tailed.
Perturbation of gene expression levels were evaluated
by the stand-alone GSEA software v2.07 offered by the
Broad Institute [26,27]. The goal was to analyze the
global perturbations of set of genes of interest, by sense
and antisense Alu transfections, in comparison with the
control samples of Hek293 cells transfected by empty
vectors. GSEA examines whether particular sets of genes
(in our case, Ant-alus and Sens-alus) tend to be the lead-
ing perturbed genes amongst all genes. When multiple
probe-sets are associated to a gene, the median of all
probe-set measurements were used to represent the gene.
The perturbation was quantified by the difference of gene
level between two treatment conditions (i.e. classes).
Family-wise error rate (FWER) P-values were derived from
an empirical distribution upon 10000 permutations of the
class labels to address multiple comparison issues.
The RNA and protein expressions were visualized as
heatmaps using Cluster 3.0 [36,37] and TreeView version
1.1.6r2 [38]. In the heatmap presentation, the expression
levels were subtracted by baseline values which were the
average measurements on naïve cells and cells with
empty vectors.
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